Insulin glargine, at a therapeutic concentration of 150 pmol/l (20 μU/ml) was added to the maternal circulation. Additional experiments were carried out at insulin glargine concentrations 1,000 ...

USA: A study published in Diabetes, Obesity and Metabolism found that insulin glargine-lixisenatide (iGlarLixi) significantly improves time-in-range (TIR) and reduces time-above-range (TAR) ...

Discover the commercial and brand names of the generic drug Insulin Glargine. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...

In adults, insulin glargine (a long-acting insulin analog) reduces the risk of nocturnal hypoglycemia and improves control of morning blood glucose levels; however, most published studies included ...

Lilly and Boehringer Ingelheim have gained EU approval for their biosimilar version of Sanofi's blockbuster insulin product Lantus (insulin glargine). The Europe-wide approval is the first ever ...